Report Detail
Global (United States, European Union and China) Intranasal Drug Delivery Market Research Report 2019-2025
- RnM3713175 |
- 30 August, 2019 |
- Global |
- 128 Pages |
- QYResearch |
- Pharma & Healthcare
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The classification of Intranasal Drug Delivery Devices includes Multidose and Uni/bidose, and the proportion of Multidose in 2017 is about 85%, and the proportion is in decreasing trend from 2013 to 2017.
North America, especially The United States, will still play an important role which cannot be ignored, with market size of 340 million USD in 2017 and will be 770 million USD in 2025. Any changes from United States might affect the development trend of Intranasal Drug Delivery Devices. North America region is the largest consumer of Intranasal Drug Delivery Devices, with a market share nearly 43% in 2017.
Europe also plays important roles in global market, with market size of 270 million USD in 2017, enjoying sales market share nearly 34% in 2017.The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
In 2019, the market size of Intranasal Drug Delivery is 780 million US$ and it will reach 1730 million US$ in 2025, growing at a CAGR of 10.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Intranasal Drug Delivery.
This report studies the global market size of Intranasal Drug Delivery, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Intranasal Drug Delivery sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
BD
AptarGroup
3M
Teleflex
H＆T Presspart
Bespak
Pfizer
Novartis
Becton Dickinson
Johnson & Johnson
Merck
GlaxoSmithKline
Nemera
OptiNose
AstraZeneca
Market Segment by Product Type
Multidose
Uni/bidose
Market Segment by Application
Personal Use
Hospital Use
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Intranasal Drug Delivery status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Intranasal Drug Delivery manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Intranasal Drug Delivery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Intranasal Drug Delivery Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Multidose
- 1.3.3 Uni/bidose
- 1.4 Market Segment by Application
- 1.4.1 Global Intranasal Drug Delivery Market Share by Application (2019-2025)
- 1.4.2 Personal Use
- 1.4.3 Hospital Use
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Intranasal Drug Delivery Market Size
- 2.1.1 Global Intranasal Drug Delivery Revenue 2014-2025
- 2.1.2 Global Intranasal Drug Delivery Sales 2014-2025
- 2.2 Intranasal Drug Delivery Growth Rate by Regions
- 2.2.1 Global Intranasal Drug Delivery Sales by Regions 2014-2019
- 2.2.2 Global Intranasal Drug Delivery Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Intranasal Drug Delivery Sales by Manufacturers
- 3.1.1 Intranasal Drug Delivery Sales by Manufacturers 2014-2019
- 3.1.2 Intranasal Drug Delivery Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Intranasal Drug Delivery Revenue by Manufacturers (2014-2019)
- 3.2.2 Intranasal Drug Delivery Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Intranasal Drug Delivery Market Concentration Ratio (CR5 and HHI)
- 3.3 Intranasal Drug Delivery Price by Manufacturers
- 3.4 Key Manufacturers Intranasal Drug Delivery Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Intranasal Drug Delivery Market
- 3.6 Key Manufacturers Intranasal Drug Delivery Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Multidose Sales and Revenue (2014-2019)
- 4.1.2 Uni/bidose Sales and Revenue (2014-2019)
- 4.2 Global Intranasal Drug Delivery Sales Market Share by Type
- 4.3 Global Intranasal Drug Delivery Revenue Market Share by Type
- 4.4 Intranasal Drug Delivery Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Intranasal Drug Delivery Sales by Application
6 United States
- 6.1 United States Intranasal Drug Delivery Breakdown Data by Company
- 6.2 United States Intranasal Drug Delivery Breakdown Data by Type
- 6.3 United States Intranasal Drug Delivery Breakdown Data by Application
7 European Union
- 7.1 European Union Intranasal Drug Delivery Breakdown Data by Company
- 7.2 European Union Intranasal Drug Delivery Breakdown Data by Type
- 7.3 European Union Intranasal Drug Delivery Breakdown Data by Application
8 China
- 8.1 China Intranasal Drug Delivery Breakdown Data by Company
- 8.2 China Intranasal Drug Delivery Breakdown Data by Type
- 8.3 China Intranasal Drug Delivery Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Intranasal Drug Delivery Breakdown Data by Company
- 9.2 Rest of World Intranasal Drug Delivery Breakdown Data by Type
- 9.3 Rest of World Intranasal Drug Delivery Breakdown Data by Application
- 9.4 Rest of World Intranasal Drug Delivery Breakdown Data by Countries
- 9.4.1 Rest of World Intranasal Drug Delivery Sales by Countries
- 9.4.2 Rest of World Intranasal Drug Delivery Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 BD
- 10.1.1 BD Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.1.4 Intranasal Drug Delivery Product Introduction
- 10.1.5 BD Recent Development
- 10.2 AptarGroup
- 10.2.1 AptarGroup Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.2.4 Intranasal Drug Delivery Product Introduction
- 10.2.5 AptarGroup Recent Development
- 10.3 3M
- 10.3.1 3M Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.3.4 Intranasal Drug Delivery Product Introduction
- 10.3.5 3M Recent Development
- 10.4 Teleflex
- 10.4.1 Teleflex Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.4.4 Intranasal Drug Delivery Product Introduction
- 10.4.5 Teleflex Recent Development
- 10.5 H＆T Presspart
- 10.5.1 H＆T Presspart Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.5.4 Intranasal Drug Delivery Product Introduction
- 10.5.5 H＆T Presspart Recent Development
- 10.6 Bespak
- 10.6.1 Bespak Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.6.4 Intranasal Drug Delivery Product Introduction
- 10.6.5 Bespak Recent Development
- 10.7 Pfizer
- 10.7.1 Pfizer Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.7.4 Intranasal Drug Delivery Product Introduction
- 10.7.5 Pfizer Recent Development
- 10.8 Novartis
- 10.8.1 Novartis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.8.4 Intranasal Drug Delivery Product Introduction
- 10.8.5 Novartis Recent Development
- 10.9 Becton Dickinson
- 10.9.1 Becton Dickinson Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.9.4 Intranasal Drug Delivery Product Introduction
- 10.9.5 Becton Dickinson Recent Development
- 10.10 Johnson & Johnson
- 10.10.1 Johnson & Johnson Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Intranasal Drug Delivery
- 10.10.4 Intranasal Drug Delivery Product Introduction
- 10.10.5 Johnson & Johnson Recent Development
- 10.11 Merck
- 10.12 GlaxoSmithKline
- 10.13 Nemera
- 10.14 OptiNose
- 10.15 AstraZeneca
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Intranasal Drug Delivery Sales Channels
- 11.2.2 Intranasal Drug Delivery Distributors
- 11.3 Intranasal Drug Delivery Customers
12 Market Forecast
- 12.1 Global Intranasal Drug Delivery Sales and Revenue Forecast 2019-2025
- 12.2 Global Intranasal Drug Delivery Sales Forecast by Type
- 12.3 Global Intranasal Drug Delivery Sales Forecast by Application
- 12.4 Intranasal Drug Delivery Forecast by Regions
- 12.4.1 Global Intranasal Drug Delivery Sales Forecast by Regions 2019-2025
- 12.4.2 Global Intranasal Drug Delivery Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Intranasal Drug Delivery. Industry analysis & Market Report on Intranasal Drug Delivery is a syndicated market report, published as Global (United States, European Union and China) Intranasal Drug Delivery Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Intranasal Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
